Responding to COVID-19: A Science-Based Approach

Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health, infectious disease, risk communication, and crisis standards of care.

Webinar #18: COVID-19 Conversations: Variants and Vaccines

Carlos del Rio  Angela Rasmussen  David Ho  Monica Gandhi

The 18th COVID-19 Conversations webinar focused on emerging COVID-19 variants, how vaccines can adapt to these new variants, and other interventions that could help curb transmission. Our expert panel: 

  • Carlos del Rio, Emory University (Moderator)
  • Angela Rasmussen, VIDO-InterVac, University of Saskatchewan; Center for Global Health Science and Security, Georgetown University
  • David D. Ho, Columbia University
  • Monica Gandhi, University of California, San Francisco and San Francisco General Hospital

Webinar participants can earn 1.5 CPH, CME, CNE, or CHES continuing education credits.

Webinar #17: A New Year of COVID — The State of the Pandemic & U.S. Strategy in 2021

George Benjamin  Rochelle Walensky  Marcella Nunez-Smith  Andy Slavitt

The latest COVID-19 Conversations webinar outlined the current state of the pandemic in the U.S. and new and continuing federal-level initiatives to curb and control the virus. Our expert panel:

  • Georges Benjamin, Executive Director, APHA (Moderator)
  • Rochelle Walensky, Director, Centers for Disease Control and Prevention
  • Marcella Nunez-Smith, Chair, COVID-19 Equity Task Force
  • Andy Slavitt, White House Senior Advisor on COVID-19 Response 

PREVIOUS WEBINARS

MORE ABOUT THE WEBINAR SERIES

The webinar series draws from and complements existing advisory activities underway at APHA and the National Academies, including the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, which was convened for the purpose of advising the White House and federal agencies on the U.S. response to COVID-19.

The series rapidly and regularly provides trustworthy scientific analysis of the latest COVID-19 developments for the benefit of policymakers, public health and health care officials, and the general public.

The series is exploring the scientific basis for guidance issued by government, health and public health organizations, and industry, as well as answering questions that are top of mind for its audiences.

Questions? Contact us.

Stay in the know

     

Questions? Need Help?